EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 54 industry peers in the Health Care Equipment & Supplies industry. BIM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. BIM has a decent growth rate and is not valued too expensively. These ratings could make BIM a good candidate for quality investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.22% | ||
ROE | 15.4% | ||
ROIC | 13.93% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 14.91% | ||
PM (TTM) | 11.01% | ||
GM | 55.73% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.08 | ||
Debt/FCF | 1.53 | ||
Altman-Z | 7.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.2 | ||
Quick Ratio | 1.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 30.1 | ||
Fwd PE | 25.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 42.78 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.8% |
EPA:BIM (3/27/2025, 11:48:43 AM)
116.2
-0.1 (-0.09%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.8% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 30.1 | ||
Fwd PE | 25.25 | ||
P/S | 2.34 | ||
P/FCF | 42.78 | ||
P/OCF | 20.61 | ||
P/B | 3.27 | ||
P/tB | 4.61 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.22% | ||
ROE | 15.4% | ||
ROCE | 18.92% | ||
ROIC | 13.93% | ||
ROICexc | 15.42% | ||
ROICexgc | 21.79% | ||
OM | 14.91% | ||
PM (TTM) | 11.01% | ||
GM | 55.73% | ||
FCFM | 5.47% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.08 | ||
Debt/FCF | 1.53 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | 5.88% | ||
Interest Coverage | 250 | ||
Cash Conversion | N/A | ||
Profit Quality | 49.65% | ||
Current Ratio | 2.2 | ||
Quick Ratio | 1.29 | ||
Altman-Z | 7.19 |